ArticleJournal of the American Chemical Society2026
The Role of Terminal Heavy Chalcogenide Ligands in Enabling Hydride Transfer Reactivity of W═E (E = S, Se) Models for Molybdenum Hydroxylases.
Article in Journal of the American Chemical Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Whereas molybdenum-dependent hydroxylases in the xanthine oxidase family catalyze site-selective C-H hydroxylation reactions using terminal molybdenum sulfide (Mo═S) active sites, certain variants such as nicotinate dehydrogenase (NDH) replace the sulfide ligand by a selenide (Mo═Se) to enable activation of less reactive C-H bonds. To probe the origins of this dependence on terminal chalcogenide identity, we prepared and crystallographically characterized a synthetic model complex of the NDH active site, [(bdt)W(O)2Se]2-, a dioxotungsten(VI) selenide complex supported by benzene-1,2-dithiolate (bdt), for comparison to the previously reported [(bdt)W(O)3]2- and [(bdt)W(O)2S]2- analogues. Electronic structure analyses combining experimental UV-vis spectroscopy and DFT calculations indicate that replacement of terminal oxo ligands by heavier chalcogenides introduces accessible low-energy acceptor orbitals associated with more spatially distributed W═E (E = S, Se) interactions. Treatment of the terminal selenido and sulfido complexes with BH4- led to reduced tungsten products accompanied by liberation of free hydroselenide (HSe-) and hydrosulfide (HS-), respectively, whereas the corresponding trioxo analogue was unreactive under analogous conditions. These findings provide direct experimental support for the proposal that terminal heavy chalcogenide ligands play an active electronic role in enabling biological hydride-transfer reactivity in molybdenum hydroxylase enzymes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.